In Preclinical Life Science, New Solutions Provide a Platform for Discovery

(DGIwire) – Once a year, the Experimental Biology conference brings together some of the most prestigious researchers involved in preclinical life science. Significantly, it convenes members of no less than five different societies: the American Association of Anatomists, the American Physiological Society, the American Society for Biochemistry and Molecular Biology, the American Society for Investigative Pathology and the American Society for Pharmacology & Experimental Therapeutics. All are seeking new solutions that can help expand the frontiers in a number of research subdisciplines.

“Today’s laboratory workers want to go beyond the status quo in life science to benefit a wide number of areas in medicine,” says Jeffrey Duchemin, President and CEO of Harvard Bioscience. “These advances are dependent on the platforms that allow basic discoveries to be made.”

At the 2019 conference, Harvard Bioscience’s three commercial units showcased products from each company—as well as newly engineered products that combined technologies from across the parent company’s portfolio—that are designed to meet specific research needs.

One unit, Data Sciences International, exhibited new implants for neuroscience capable of collecting up to four biopotential channels, temperature and activity in small and large animals. These enable the collection of stress-free data from mice, rats and large animals. Also exhibited was technology that gives researchers the ability to monitor two pressures, temperature, activity and other data, allowing a more complete physiology assessment from a single animal.

A second unit, Ephys, exhibited the Smart Ephys Wireless System, the newest addition to the division’s wireless, tethered and implantable in vivo portfolio. This system combines the advantages of technology from two Harvard subsidiaries, Triangle BioSystems International and Multi Channel Systems, such as digital data acquisition. Also on display was an array system designed to measure glucose-induced electrical activity from regions of the pancreas that contain its endocrine cells.

The third unit, Physiology, Cell and Molecular Instruments, also exhibited a range of products used for the advancement of life science research. For example, the Harvard Apparatus subsidiary exhibited a full suite of surgical equipment including anesthesia, ventilators, temperature control and vital signs monitoring. Meanwhile, the BTX subsidiary exhibited systems that enable effective methods of transporting substances into cells, tissues and organisms.

“Tomorrow’s life science breakthroughs have their origins in work being conducted in the laboratory today, and technology is helping usher in a brave new future in this regard,” Duchemin adds.